PACB Pacific Biosciences of California Inc
13,827
$2.03
$0.195
(10.66%)
| Watchers | 13,827 |
| 52-Wk Low | $1.25 |
| 52-Wk High | $14.55 |
| Market Cap | $498.39M |
| Volume | 14.72M |
| 52-Wk High | $14.55 |
| 52-Wk Low | $1.25 |
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue GuidancePR Newswire • 20 days ago
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance PR Newswire MENLO...
Share to Feed
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the twelve research firms that are covering the...
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes PR Newswire MENLO PARK, Calif., March 27, 2024 HiFi...
Pacific Biosciences of California, Inc. (NASDAQ:PACB Get Free Report)s stock price gapped up prior to trading on Monday . The stock had previously closed at $3.68, but opened at $3.81...
StockNews.com upgraded shares of Pacific Biosciences of California (NASDAQ:PACB Free Report) to a sell rating in a research note issued to investors on Wednesday. A number of other brokerages...
PacBio Grants Equity Incentive Award to New Employee PacBio Grants Equity Incentive Award to New Employee PR Newswire MENLO PARK, Calif., March 22, 2024 MENLO PARK, Calif., March 22, 2024...
This is a signal that PACB's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Pacific Biosciences of California, Inc. (NASDAQ:PACB Get Free Report) insider Michele Farmer sold 2,968 shares of Pacific Biosciences of California stock in a transaction dated Monday, March...
Pacific Biosciences of California, Inc. (NASDAQ:PACB Get Free Report) dropped 5% during trading on Tuesday . The company traded as low as $4.16 and last traded at $4.18. Approximately...
PacBio Announces PureTarget Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions PacBio Announces PureTarget Repeat Expansion Panel, Expanding its Portfolio of...